Benchtop proof of concept and comparison of iron- and magnesium-based bioresorbable flow diverters
- PMID: 36681964
- PMCID: PMC10824252
- DOI: 10.3171/2022.11.JNS222213
Benchtop proof of concept and comparison of iron- and magnesium-based bioresorbable flow diverters
Abstract
Objective: Bioresorbable flow diverters (BRFDs) could significantly improve the performance of next-generation flow diverter technology. In the current work, magnesium and iron alloy BRFDs were prototyped and compared in terms of porosity/pore density, radial strength, flow diversion functionality, and resorption kinetics to offer insights into selecting the best available bioresorbable metal candidate for the BRFD application.
Methods: BRFDs were constructed with braided wires made from alloys of magnesium (MgBRFD) or iron (FeBRFD). Pore density and crush resistance force were measured using established methods. BRFDs were deployed in silicone aneurysm models attached to flow loops to investigate flow diversion functionality and resorption kinetics in a simulated physiological environment.
Results: The FeBRFD exhibited higher pore density (9.9 vs 4.3 pores/mm2) and crush resistance force (0.69 ± 0.05 vs 0.53 ± 0.05 N/cm, p = 0.0765, n = 3 per group) than the MgBRFD, although both crush resistances were within the range previously reported for FDA-approved flow diverters. The FeBRFD demonstrated greater flow diversion functionality than the MgBRFD, with significantly higher values of established flow diversion metrics (mean transit time 159.6 ± 11.9 vs 110.9 ± 1.6, p = 0.015; inverse washout slope 192.5 ± 9.0 vs 116.5 ± 1.5, p = 0.001; n = 3 per group; both metrics expressed as a percentage of the control condition). Last, the FeBRFD was able to maintain its braided structure for > 12 weeks, whereas the MgBRFD was almost completely resorbed after 5 weeks.
Conclusions: The results of this study demonstrated the ability to manufacture BRFDs with magnesium and iron alloys. The data suggest that the iron alloy is the superior material candidate for the BRFD application due to its higher mechanical strength and lower resorption rate relative to the magnesium alloy.
Keywords: absorbable; bioabsorbable; biodegradable; bioresorbable; endovascular neurosurgery; flow diverter; stent.
Figures




Similar articles
-
Medical Imaging Compatibility of Magnesium- and Iron-Based Bioresorbable Flow Diverters.AJNR Am J Neuroradiol. 2023 Jun;44(6):668-674. doi: 10.3174/ajnr.A7873. Epub 2023 May 11. AJNR Am J Neuroradiol. 2023. PMID: 37169543 Free PMC article.
-
Evaluation of FeMnN alloy bioresorbable flow diverters in the rabbit elastase induced aneurysm model.Front Bioeng Biotechnol. 2025 Feb 25;13:1522696. doi: 10.3389/fbioe.2025.1522696. eCollection 2025. Front Bioeng Biotechnol. 2025. PMID: 40070550 Free PMC article.
-
Magnesium-based bioresorbable flow diverter for intracranial aneurysms: a pilot study of biocompatibility and bioresorption in a rabbit vascular model.J Neurointerv Surg. 2025 Jan 27:jnis-2024-022527. doi: 10.1136/jnis-2024-022527. Online ahead of print. J Neurointerv Surg. 2025. PMID: 39567187
-
Bioresorbable flow diverters for the treatment of intracranial aneurysms: review of current literature and future directions.J Neurointerv Surg. 2023 Feb;15(2):178-182. doi: 10.1136/neurintsurg-2022-018941. Epub 2022 May 30. J Neurointerv Surg. 2023. PMID: 35636949 Free PMC article. Review.
-
Prospects and strategies for magnesium alloys as biodegradable implants from crystalline to bulk metallic glasses and composites-A review.Acta Biomater. 2020 Feb;103:1-23. doi: 10.1016/j.actbio.2019.12.023. Epub 2019 Dec 24. Acta Biomater. 2020. PMID: 31881312 Review.
Cited by
-
Medical Imaging Compatibility of Magnesium- and Iron-Based Bioresorbable Flow Diverters.AJNR Am J Neuroradiol. 2023 Jun;44(6):668-674. doi: 10.3174/ajnr.A7873. Epub 2023 May 11. AJNR Am J Neuroradiol. 2023. PMID: 37169543 Free PMC article.
-
Radiopaque FeMnN-Mo composite drawn filled tubing wires for braided absorbable neurovascular devices.Bioact Mater. 2024 Jun 7;40:74-87. doi: 10.1016/j.bioactmat.2024.06.002. eCollection 2024 Oct. Bioact Mater. 2024. PMID: 38962657 Free PMC article.
-
Evaluation of FeMnN alloy bioresorbable flow diverting stents in the rabbit abdominal aorta.Bioact Mater. 2025 Feb 12;48:18-28. doi: 10.1016/j.bioactmat.2025.01.039. eCollection 2025 Jun. Bioact Mater. 2025. PMID: 40303967 Free PMC article.
-
Endothelial Progenitor Cells: A Review of Molecular Mechanisms in the Pathogenesis and Endovascular Treatment of Intracranial Aneurysms.Neuromolecular Med. 2024 Jun 17;26(1):25. doi: 10.1007/s12017-024-08791-4. Neuromolecular Med. 2024. PMID: 38886284 Review.
-
Evaluation of FeMnN alloy bioresorbable flow diverters in the rabbit elastase induced aneurysm model.Front Bioeng Biotechnol. 2025 Feb 25;13:1522696. doi: 10.3389/fbioe.2025.1522696. eCollection 2025. Front Bioeng Biotechnol. 2025. PMID: 40070550 Free PMC article.
References
-
- Brinjikji W, Murad MH, Lanzino G, Cloft HJ, Kallmes DF. Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis. Stroke. 2013;44(2):442–447. - PubMed
-
- Dandapat S, Mendez-Ruiz A, Martínez-Galdámez M, et al. Review of current intracranial aneurysm flow diversion technology and clinical use. Journal of NeuroInterventional Surgery. 2021;13(1):54–62. - PubMed
-
- Becske T, Brinjikji W, Potts MB, et al. Long-term clinical and angiographic outcomes following pipeline embolization device treatment of complex internal carotid artery aneurysms: five-year results of the pipeline for uncoilable or failed aneurysms trial. Neurosurgery. 2017;80(1):40–48. - PubMed
-
- Guédon A, Clarençon F, Di Maria F, et al. Very late ischemic complications in flow-diverter stents: a retrospective analysis of a single-center series. Journal of neurosurgery. 2016;125(4):929–935. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical